SUBSCRIBE
SUBSCRIBE

Alkermes

NEWS
Biotech Beach
The Day In Review: Dyax Corp. Jumps On Positive Data
April 13, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Novartis Pharmaceuticals Corporation Gets Approval For Hypertensive Drug Tekturna
March 6, 2007
 · 
1 min read
BioForest
The Day In Review: Seattle Genetics, Inc. Sells Cancer Drug To Genentech, Inc.
January 8, 2007
 · 
1 min read
Biotech Bay
Alkermes More Than A Drug Delivery Company
July 17, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Alkermes And Cephalon, Inc. Alcohol Drug Gets Approvable Letter
December 29, 2005
 · 
1 min read
Alkermes’ Alcohol Alchemy
October 19, 2005
 · 
1 min read
Drug Development
The Day In Review: Biotech Gains A Substantial 1+%; A Wealth of Positive News Helps Sector Move Higher
October 19, 2005
 · 
1 min read
Policy
U.S. Study Backs Injectable Drug For Alcoholism
October 19, 2005
 · 
1 min read
Bated Breath For Inhaled Insulin
October 19, 2005
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
February 25, 2026
 · 
1 min read
Press Releases
Alkermes plc Announces CEO Succession Plan
February 25, 2026
 · 
9 min read
Press Releases
Alkermes to Present at the TD Cowen 46th Annual Health Care Conference
February 25, 2026
 · 
1 min read
Press Releases
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
February 12, 2026
 · 
13 min read
Press Releases
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
February 12, 2026
 · 
1 min read
Press Releases
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
January 6, 2026
 · 
5 min read
Press Releases
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 30, 2025
 · 
1 min read
Press Releases
Alkermes to Participate in Two Upcoming December 2025 Investor Conferences
November 26, 2025
 · 
1 min read
Press Releases
Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2
November 13, 2025
 · 
11 min read
Press Releases
Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1
July 21, 2025
 · 
11 min read
Load More